• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Investor Summit Group Provides Update on Upcoming Q4 Virtual Summit

    11/5/21 6:05:05 PM ET
    $ABIO
    $ACST
    $ALIM
    $AMST
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABIO alert in real time by email

    NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The Investor Summit Group, widely recognized for its reputation as the host of North America's largest independent investor conferences, will be hosting the upcoming Q4 Virtual Summit on November 16-17. The event will bring together some of the continent's most exciting and influential small and micro-cap companies, providing presenting companies with the unique opportunity to meet and interact with leading investors.

    This year's Q4 Virtual Summit will feature a selection of more than 90 carefully curated companies drawn from a wide variety of sectors, including healthcare, financial, technology, crypto, energy, industrials, financials, and materials. The event will host upwards of 500 investors, including institutional investors, family offices, high-net-worth individuals and regulated investor advisors in the space. 

    "The Investor Summit provides us the opportunity to meet with current shareholders, interact with prospective investors, and showcase to the broader investment community our recent developments and successes," said Michael Pope, President of Boxlight Corporation, one of the many small-cap companies that have presented in the past. 

    This year's Q4 event will contain a series of live, 30-minute corporate presentations throughout the conference on four distinct tracks with investors able to attend the company presentation of their choice.  For qualified investors, 1x1s will also be available. With the U.S. economy returning from a period of extended closure on the back of the COVID-19 outbreak, investors will have the invaluable opportunity to glean insights and ascertain operational updates from a series of small and micro-cap leaders.

    To register for the upcoming Q4 Virtual Summit, visit https://investorsummitgroup.com.

    A2Z Smart Technologies (TSX:AZ) (OTCQB:AAZZF)

    Acasti Pharma (NASDAQ:ACST)

    Actinium Pharmaceuticals, Inc. (NYSE:ATNM)

    Adcore Inc. (TSX:ADCO) (OTCQX:ADCOF)

    Alimera Sciences (NASDAQ:ALIM)

    Alpha Cognition (TSX:ACOG) (OTCQB:ACOGF)

    Amesite Inc. (NASDAQ:AMST)

    Annovis Bio, Inc. (NYSE:ANVS)

    AnPac Bio (NASDAQ:ANPC)

    ARC Document Solutions (NASDAQ:ARC)

    ARCA Biopharma, Inc. (NASDAQ:ABIO)

    Artelo Biosciences (NASDAQ:ARTL)

    Assertio Holdings, Inc. (NASDAQ:ASRT)

    Auddia Inc. (NASDAQ:AUUD)

    Avalon Advanced Materials Inc. (TSX:AVL) (OTCQB:AVLNF)

    Banxa (TSX:BNXA) (OTCQX:BNXAF)

    Basanite Inc. (OTCQB:BASA)

    Battery Mineral Resources Corp. (TSX:BMR)

    BeWhere Holdings Inc. (TSX:BEW)

    BioCorRx Inc. (OTCQB:BICX)

    BlackBird LLP (AIM: BIRD) (OTCQX:BBRDF)

    Boardwalktech Software (TSX:BWLK) (OTCQB:BWLKF)

    BrainChip Holdings Inc. (ASX: BRN) (OTCQX:BRCHF)

    BriaCell Therapeutics Corp. (TSX:BCT) (NASDAQ:BCTX)

    Cadente Copper Corp. (TSX:DNT)

    Canagold Resources Ltd. (TSX:CCM) (OTCQB:CRCUF)

    Chalice Brands Ltd. (CSE:CHAL) (OTCQB:CHALF)

    Charah Solutions (NYSE:CHRA)

    Cloudcall Group plc (AIM: CALL) (OTCQX:CLLF)

    DATA Communications Management Corp. (TSX:DCM) (OTC:DGPIF)

    Data Storage Corporation (NASDAQ:DTST)

    Diamcor Mining Inc. (TSX:DMI) (OTCQB:DMIFF)

    Dynatronics Corporation (NASDAQ:DYNT)

    Emmaus Life Sciences, Inc. (OTCQX:EMMA)

    Enveric Biosciences (NASDAQ:ENVB)

    FansUnite Entertainment Inc. (CSE:FANS) (OTCQX:FUNFF)

    Feldan Therapeutics (Private Company)

    First Cobalt Corp. (TSX:FCC) (OTCQX:FTSSF)

    Focus Universal (NASDAQ:FCUV)

    GEE GROUP (NYSE:JOB)

    Harbor Custom Development, Inc. (NASDAQ:HCDI)

    HyreCar Inc. (NASDAQ:HYRE)

    International Land Alliance (OTCQB:ILAL)

    Khiron Life Sciences Corp. (CSE:KHRN) (OTCQX:KHRNF)

    Kintara Therapeutics, Inc. (NASDAQ:KTRA)

    KULR Technology Group, Inc. (NYSE:KULR)

    Lantern Pharma Inc. (NASDAQ:LTRN)

    LiveXLive Media (NASDAQ:LVO)

    Lobe Sciences (CSE:LOBE) (OTC:GTSIF)

    Mace Security International (OTCQX:MACE)

    ME2C Environmental (OTCQB:MEEC)

    Mechanical Technology, Inc. (NASDAQ:MKTY)

    Medexus Pharma (TSX:MDP) (OTCQX:MEDXF)

    Metamaterial Inc. (NASDAQ:MMAT)

    Nephros, Inc. (NASDAQ:NEPH)

    Neurosome Sleep Therapy / BEL Company (Private Company)

    Nova Leap Health Corp. (TSX:NLH) (OTCQX:NVLPF)

    Origin Agritech Ltd (NASDAQ:SEED)

    Perimeter Medical Imaging (TSX:PINK) (OTC:PYNKF)

    Petros Pharmaceuticals, Inc. (Metuchen) (NASDAQ:PTPI)

    Pluristem Therapeutics (NASDAQ:PSTI)

    ProMIS Neurosciences, Inc. (TSX:PMN) (OTCQB:ARFXF)

    ProPhase Labs (NASDAQ:PRPH)

    PyroGenesis Canada Inc. (NASDAQ:PYR)

    Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)

    Recruiter.com Group, Inc. (NASDAQ:RCRT)

    Red Cat Holdings, Inc. (NASDAQ:RCAT)

    Renavotio Inc. (OTCQB:RIII)

    Riley Exploration Permian (NYSE:REPX)

    Safehold Inc. (NASDAQ:SAFE)

    Salem Media Group, Inc. (NASDAQ:SALM)

    Sigyn Therapeutics, Inc. (OTC:SIGY)

    Soluna Holdings (Aka Mechanical Technology) (NASDAQ:SLNH)

    Snipp Interactive Inc. (TSX:SPN) (OTC:SNIPF)

    Spectral Medical Inc. (TSX:EDT)

    StoneCastle Financial Corp. (NASDAQ:BANX)

    Tego Cyber Inc. (OTCQB:TGCB)

    The Andersons (NASDAQ:ANDE)

    Thermal Energy International (TSX:TMG) (OTCQB:TMGEF)

    Tonix Pharmaceuticals (NASDAQ:TNXP)

    Tower One Wireless Corp. (CSE:TO) (OTCQB:TOWTF)

    Townsquare Media Inc. (NASDAQ:TSQ)

    TransCode Therapeutics (NASDAQ:RNAZ)

    Ur-Energy Inc. (NYSE:URG)

    VersaBank (TSX:VB) (NASDAQ:VBNK)

    Vertical Capital Income Fund (NASDAQ:VCIF)

    Vivos Therapeutics, Inc. (NASDAQ:VVOS)

    VolitionRx Ltd. (NYSE:VNRX)

    Vyant Bio, Inc. (NASDAQ:VYNT)

    XPhyto Therapeutics Corp. (CSE:XPHY) (OTCQB:XPHYF)

    Ynvisible Interactive Inc. (TSX:YNV) (OTCQB:YNVYF)

    About Investor Summit Group (ISG)

    Investor Summit Group (formerly MicroCap Conference) hosts the largest independent investor conference on the East Coast. Its independence allows conference organizers to focus on customer service and scheduling high-quality meetings between the executives and investors who attend. The ISG team sets the bar for quality service in a space traditionally dominated by banks that focus more on selling their services than on building the connections companies need to succeed. ISG has facilitated countless valuable interactions for its presenting companies, which have often led to increased exposure, market value appreciation and long-term growth.

    For more information, visit www.investorsummitgroup.com.

    General Inquiries:

    Sasha Murray

    Director of IR and Sales

    [email protected]

    Corporate Communications:

    IBN (InvestorBrandNetwork)

    Los Angeles, California

    www.IBN.com

    310.299.1717 Office

    [email protected]



    Primary Logo

    Get the next $ABIO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABIO
    $ACST
    $ALIM
    $AMST

    CompanyDatePrice TargetRatingAnalyst
    Assertio Holdings Inc.
    $ASRT
    4/9/2026$18.00Buy → Neutral
    H.C. Wainwright
    Ur Energy Inc
    $URG
    4/3/2026Buy
    Canaccord Genuity
    Ur Energy Inc
    $URG
    4/2/2026Buy
    Canaccord Genuity
    Riley Exploration Permian Inc.
    $REPX
    3/24/2026$47.00Buy
    Truist
    Andersons Inc.
    $ANDE
    2/5/2026$75.00Buy
    The Benchmark Company
    Andersons Inc.
    $ANDE
    2/5/2026Buy
    The Benchmark Company
    Safehold Inc. New
    $SAFE
    1/23/2026$14.00Equal-Weight → Underweight
    Morgan Stanley
    Andersons Inc.
    $ANDE
    12/10/2025$65.00Market Perform → Outperform
    BMO Capital Markets
    More analyst ratings

    $ABIO
    $ACST
    $ALIM
    $AMST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Assertio Therapeutics downgraded by H.C. Wainwright with a new price target

    H.C. Wainwright downgraded Assertio Therapeutics from Buy to Neutral and set a new price target of $18.00

    4/9/26 8:30:00 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Ur-Energy

    Canaccord Genuity initiated coverage of Ur-Energy with a rating of Buy

    4/3/26 10:44:59 AM ET
    $URG
    Precious Metals
    Basic Materials

    Canaccord Genuity initiated coverage on Ur-Energy

    Canaccord Genuity initiated coverage of Ur-Energy with a rating of Buy

    4/2/26 8:22:26 AM ET
    $URG
    Precious Metals
    Basic Materials

    $ABIO
    $ACST
    $ALIM
    $AMST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Finance Op and Tech Schatz Scott bought $6,478 worth of shares (980 units at $6.61), increasing direct ownership by 2% to 58,051 units (SEC Form 4)

    4 - Townsquare Media, Inc. (0001499832) (Issuer)

    2/4/26 4:51:27 PM ET
    $TSQ
    Broadcasting
    Consumer Discretionary

    Director Hoffman Michael B bought $193,794 worth of shares (45,000 units at $4.31), increasing direct ownership by 2% to 2,574,739 units (SEC Form 4)

    4 - Annovis Bio, Inc. (0001477845) (Issuer)

    12/8/25 8:05:14 PM ET
    $ANVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Director Hoffman Michael B bought $159,886 worth of shares (39,200 units at $4.08), increasing direct ownership by 2% to 2,529,739 units (SEC Form 4)

    4/A - Annovis Bio, Inc. (0001477845) (Issuer)

    11/25/25 6:59:54 PM ET
    $ANVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABIO
    $ACST
    $ALIM
    $AMST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    A $550 Billion Opportunity: Drones-as-a-Service Emerges as Defense's Next Growth Engine

    Governments are accelerating investments in scalable autonomous drone operations without the burden of fleet ownershipMarket News Updates News Commentary CounterNEW YORK, April 23, 2026 /CNW/ -- Drones-as-a-Service (DaaS) is quickly becoming a major shift in how military and defense organizations actually use drone technology in the field. Instead of spending heavily to purchase and maintain their own fleets, agencies can now tap into drone capabilities like aerial surveillance, mapping, logistics delivery, and ISR (intelligence, surveillance, and reconnaissance) whenever they're needed. It works a lot like a cloud subscription model—giving operators access to the latest hardware, AI-powered

    4/23/26 9:00:00 AM ET
    $PRZO
    $RCAT
    $UAVS
    Military/Government/Technical
    Industrials
    Computer Software: Prepackaged Software
    Technology

    VolitionRx Announces Acceptance of Compliance Plan by NYSE American

    HENDERSON, Nev., April 23, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that on April 22, 2026, the NYSE American LLC (the "NYSE American") accepted the Company's plan of compliance for continued listing on the exchange. As previously reported, on February 6, 2026, the Company received a notice from the NYSE American stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the "Company Guide") requiring a company to have stockholders' equity of at least $2.0 million if it has reported losses fro

    4/23/26 8:12:00 AM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Auddia Expands AI Infrastructure Moat with 14th Patent Supporting Distributed Edge Data Center Deployments

    New patent strengthens LT350's canopy based AI deployment architecture that turns the airspace of parking lots into distributed AI inference datacenters at the edge Portfolio now spans 14 issued and 2 pending patents across the canopy and modular cartridges that support power, cooling, and modular AI compute LT350 technology solves the biggest constraints in AI infrastructure — land, power, cooling, and community compatibility BOULDER, Colo., April 23, 2026 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) ("Auddia" or the "Company") announced today that the U.S. Patent and Trademark Office has notified the company that LT350's 14th patent will be allowed, further expanding the intellectual

    4/23/26 6:00:00 AM ET
    $AUUD
    EDP Services
    Technology

    $ABIO
    $ACST
    $ALIM
    $AMST
    SEC Filings

    View All

    SEC Form S-1 filed by Focus Universal Inc.

    S-1 - FOCUS UNIVERSAL INC. (0001590418) (Filer)

    4/23/26 5:20:41 PM ET
    $FCUV
    Industrial Machinery/Components
    Industrials

    SEC Form S-3 filed by Enveric Biosciences Inc.

    S-3 - Enveric Biosciences, Inc. (0000890821) (Filer)

    4/23/26 4:30:47 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by LiveOne Inc.

    424B5 - LiveOne, Inc. (0001491419) (Filer)

    4/23/26 4:30:11 PM ET
    $LVO
    Restaurants
    Consumer Discretionary

    $ABIO
    $ACST
    $ALIM
    $AMST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Bowe Patrick E.

    4 - Andersons, Inc. (0000821026) (Issuer)

    4/23/26 11:54:06 AM ET
    $ANDE
    Farming/Seeds/Milling
    Industrials

    SEC Form 4 filed by Canter Shawn

    4 - KULR Technology Group, Inc. (0001662684) (Issuer)

    4/17/26 9:30:17 PM ET
    $KULR
    Electrical Products
    Technology

    SEC Form 4 filed by Ridings Barry W

    4 - Safehold Inc. (0001095651) (Issuer)

    4/17/26 8:00:05 AM ET
    $SAFE
    Real Estate Investment Trusts
    Real Estate

    $ABIO
    $ACST
    $ALIM
    $AMST
    Financials

    Live finance-specific insights

    View All

    Safehold Sets First Quarter 2026 Earnings Release Date and Webcast

    NEW YORK, April 22, 2026 /PRNewswire/ -- Safehold Inc. (NYSE:SAFE) announced today that it will release its financial results for the first quarter 2026 after the market close on Thursday, April 30, 2026. The Company will host an earnings conference call reviewing these results and its operations beginning at 5:00 p.m. ET on Thursday, April 30, 2026. This conference call will be broadcast live and can be accessed by all interested parties through Safehold's website, www.safeholdinc.com, in the "Investors" section.The dial-in information for the live call is:Dial-in:877.545.0523I

    4/22/26 4:05:00 PM ET
    $SAFE
    Real Estate Investment Trusts
    Real Estate

    LiveOne (Nasdaq: LVO) Eliminates $15M+ Short-Term Liabilities, Delivering $13M+ in Cash Savings; Expands Stock Conversion Program to $15M+ at $7.50 per Share, with $8M Completed

    LOS ANGELES, April 22, 2026 (GLOBE NEWSWIRE) -- LiveOne (NASDAQ:LVO), a leading music, entertainment, and technology platform, today announced a series of strategic financial and operational milestones that significantly enhance its balance sheet and reinforce long-term growth initiatives. "This is an important step toward strengthening our balance sheet and eliminating going concern opinions," said Robert Ellin, Chairman and CEO of LiveOne. "By reducing near-term obligations and executing on our stock conversion strategy, we are enhancing financial stability and positioning the Company for long-term growth." About LiveOne Headquartered in Los Angeles, CA, LiveOne (Nasdaq: LVO) is an aw

    4/22/26 8:00:00 AM ET
    $LVO
    Restaurants
    Consumer Discretionary

    Vivos Therapeutics Reports Full Year 2025 Financial Results

    Full Year 2025 revenue increased 16% Integration of The Sleep Center of Nevada and shift in business model support path to improved revenues, margins and cash flow Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., April 15, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ:VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea ("OSA"), today reported financial results and operating highlights for the full year ended December 31, 2025. Full Year 2025 Financial and Operating Summary R

    4/15/26 4:20:00 PM ET
    $VVOS
    Medical/Dental Instruments
    Health Care

    $ABIO
    $ACST
    $ALIM
    $AMST
    Leadership Updates

    Live Leadership Updates

    View All

    Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership

    SOUTH ORANGE, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced an expansion of its strategic focus in the Greater New York City region with the addition of Dana Cunningham as a dedicated regional sales leader. The Greater New York market represents one of the most densely populated and infrastructure-intensive regions in the United States, with a high concentration of healthcare facilities, aging water systems, and increasing regulatory and operational focus on waterborne pathogen risk. Based on internal estimates, Nephros believes this region repre

    4/16/26 9:57:04 AM ET
    $NEPH
    Medical/Dental Instruments
    Health Care

    As the Counter-Drone Era Goes Mainstream, This Nasdaq AI Defense Stock Just Landed a World Cup Deployment Order

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this commentary include: VisionWave Holdings, Inc. (NASDAQ:VWAV), Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), Red Cat Holdings, Inc. (NASDAQ:RCAT), Ondas Holdings Inc. (NASDAQ:ONDS), Unusual Machines, Inc. (NYSE:UMAC). Key Takeaways: The global counter-drone market has become one of the fastest-growing niches in defense, driven by the proliferation of cheap weaponized UAS across battlefields and public events.VisionWave Holdings (NASDAQ:VWAV) presented its three-pillar technology platform — VisionRF™, Stratum™, and qSpeed™ — to more than 580 investors at the 91st Emerging Growth Conference on April 2,

    4/16/26 9:00:00 AM ET
    $KTOS
    $ONDS
    $RCAT
    Military/Government/Technical
    Industrials
    Radio And Television Broadcasting And Communications Equipment
    Technology

    VERSABANK ANNOUNCES THE RESULTS OF ITS 2026 MEETING OF SHAREHOLDERS

    LONDON, ON, April 9, 2026 /CNW/ - VersaBank (TSX:VBNK) (NASDAQ:VBNK) ("VersaBank" or the "Bank") reports the results of its 2026 Annual and Special Meeting of Shareholders (the "Meeting") held in London, Ontario on April 8, 2026. Each of the director nominees listed in VersaBank's Management Information Circular dated March 9, 2026, were elected as directors of the Bank. The detailed results of the vote are as follows, with percentages rounded to two decimal places:DirectorNumber of Votes CastPercentage of Votes CastThe Honourable Frank NewbouldIn Favour:Withheld:10,971,287161,2

    4/9/26 7:55:00 AM ET
    $VBNK
    Commercial Banks
    Finance

    $ABIO
    $ACST
    $ALIM
    $AMST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BriaCell Therapeutics Corp.

    SC 13D/A - BriaCell Therapeutics Corp. (0001610820) (Subject)

    12/12/24 6:06:07 AM ET
    $BCTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by BriaCell Therapeutics Corp.

    SC 13D/A - BriaCell Therapeutics Corp. (0001610820) (Subject)

    12/10/24 6:06:45 AM ET
    $BCTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Red Cat Holdings Inc.

    SC 13G/A - Red Cat Holdings, Inc. (0000748268) (Subject)

    12/6/24 4:32:04 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    $ABIO
    $ACST
    $ALIM
    $AMST
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care